- Home
- Labeler Index
- Fresenius Kabi Usa, Llc
- 63323-416
- NDC Crossover: 63323-416 Cisatracurium
NDC Crossover 63323-416 Cisatracurium
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Cisatracurium Besylate
Explore similar products and medications to NDC 63323-416 Cisatracurium a human prescription drug with other products crossover matching the same product name (Cisatracurium) or generic name (Cisatracurium Besylate), and the same administration route (intravenous) or dosage form (injection, solution). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0409-1098 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Hospira, Inc. | Human Prescription Drug |
0409-1103 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Hospira, Inc. | Human Prescription Drug |
0409-1208 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Hospira, Inc. | Human Prescription Drug |
0409-3670 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Hospira, Inc. | Human Prescription Drug |
0409-5547 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Hospira, Inc. | Human Prescription Drug |
0409-7083 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Hospira, Inc. | Human Prescription Drug |
25021-668 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Sagent Pharmaceuticals | Human Prescription Drug |
25021-669 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Sagent Pharmaceuticals | Human Prescription Drug |
25021-670 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Sagent Pharmaceuticals | Human Prescription Drug |
63323-417 | Cisatracurium | Cisatracurium Besylate | Injection, Solution | Intravenous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-418 | Cisatracurium | Cisatracurium Besylate | Injection, Solution | Intravenous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
71288-712 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Meitheal Pharmaceuticals Inc. | Human Prescription Drug |
71288-713 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Meitheal Pharmaceuticals Inc. | Human Prescription Drug |
71288-714 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Meitheal Pharmaceuticals Inc. | Human Prescription Drug |
71288-720 | Cisatracurium Besylate | Cisatracurium Besylate | Injection, Solution | Intravenous | Meitheal Pharmaceuticals Inc. | Human Prescription Drug |